IndraLab

Statements

Hydroxychloroquine inhibits LDL. 3 / 3
| 3
reach
"For example, Hydroxychloroquine (HCQ), a DMARD used in the management of RA and SLE, has been reported to produce a less atherogenic lipid profile by lowering TC, LDL and TG and increasing HDL levels [XREF_BIBR, XREF_BIBR]."
21660202
reach
"A recent systematic review and meta-analysis involving data from nine studies and 823 participants has stated that HCQ significantly reduced mean total cholesterol plasmatic levels (26.8 mg/dL; 95% CI 8.3-45.3), as well as mean LDL serum levels (24.3 mg/dL; CI95% 8.9-39.8)."
32517786
reach
"A recent systematic review and meta-analysis involving data from nine studies and 823 participants has stated that HCQ significantly reduced mean total cholesterol plasmatic levels (26.8 mg/dL; 95% CI 8.3-45.3), as well as mean LDL serum levels (24.3 mg/dL; CI95% 8.9-39.8)."
32517786